For instance, low-frequency whole-body electromyostimulation has been shown to improve physical performance, reduce fatigue, and decrease serum α-synuclein while increasing BDNF levels in PD patients, offering a potential therapeutic approach to mitigate both motor and non-motor symptoms [6]. Here, SNCG is linked to Parkinson disease.